Can Thyroidectomy be Considered Safe in Obese Patients?

Obesity Clinical Trial

Official title:

Can Thyroidectomy be Considered Safe in Obese Patients? Retrospective Cohort Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04273711
• Other study ID #: NP20193369
• Status: Completed
• Start date: December 1, 2019
• Est. completion date: February 1, 2020

Study information

• Verified date: February 2020
• Source: University of Cagliari
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Obesity is a growing public health concern in most western countries. More and more patients with high body mass index (BMI) are undergoing surgical procedures of all kinds and, in this context, obese patients are undergoing thyroid surgery more than ever before. This study showed that obesity, in the field of thyroid surgery, is not associated with any increase of postoperative complications. Thus, it is possible to conclude that thyroidectomy can be performed safely in obese patients.

Description:

Background: Obesity is a growing public health concern in most western countries. More and more patients with high body mass index (BMI) are undergoing surgical procedures of all kinds and, in this context, obese patients are undergoing thyroid surgery more than ever before. The aim of the present study was to evaluate whether thyroidectomy can be considered safe in obese patients.

Methods: Patients undergoing thyroidectomy in our Unit between January 2014 and December 2018 were retrospectively analysed. Patients were divided into 2 groups: those with BMI < 30 kg/m2 were included in Group A, while those with BMI ≥ 30 kg/m2 in Group B.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 813
• Est. completion date: February 1, 2020
• Est. primary completion date: January 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients submitted to thyroidectomy in our Unit

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Obesity
• Surgery--Complications
• Thyroid

Locations

Country	Name	City	State
Italy	Policlinico di Monserrato	Monserrato	CA

Sponsors (1)

Lead Sponsor	Collaborator
University of Cagliari

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Postoperative stay	Evaluation of postoperative stay	up to 2 weeks
Primary	Postoperative complications	Occurrence of postoperative complications	1 year
Secondary	Operative time	Evaluation of operatives times	1 day